183 related articles for article (PubMed ID: 23919754)
1. Myxoinflammatory fibroblastic sarcoma in children and adolescents: clinicopathologic aspects of a rare neoplasm.
Weiss VL; Antonescu CR; Alaggio R; Cates JM; Gaskin D; Stefanovici C; Coffin CM
Pediatr Dev Pathol; 2013; 16(6):425-31. PubMed ID: 23919754
[TBL] [Abstract][Full Text] [Related]
2. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
3. [Myxoinflammatory fibroblastic sarcoma: a clinicopathologic study of 6 cases with review of literature].
Xiang H; Shi XL; Li QX; Zhang W; Wang J
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):94-8. PubMed ID: 21426804
[TBL] [Abstract][Full Text] [Related]
4. High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases.
Michal M; Kazakov DV; Hadravský L; Kinkor Z; Kuroda N; Michal M
Ann Diagn Pathol; 2015 Jun; 19(3):157-63. PubMed ID: 25886867
[TBL] [Abstract][Full Text] [Related]
5. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
6. Acral myxoinflammatory fibroblastic sarcoma: case series and immunohistochemical analysis.
Kovarik CL; Barrett T; Auerbach A; Cassarino DS
J Cutan Pathol; 2008 Feb; 35(2):192-6. PubMed ID: 18190444
[TBL] [Abstract][Full Text] [Related]
7. Superficial acral fibromyxoma: a clinicopathologic and immunohistochemical analysis of 37 cases of a distinctive soft tissue tumor with a predilection for the fingers and toes.
Fetsch JF; Laskin WB; Miettinen M
Hum Pathol; 2001 Jul; 32(7):704-14. PubMed ID: 11486169
[TBL] [Abstract][Full Text] [Related]
8. Acral myxoinflammatory fibroblastic sarcomas: are they all low-grade neoplasms?
Hassanein AM; Atkinson SP; Al-Quran SZ; Jain SM; Reith JD
J Cutan Pathol; 2008 Feb; 35(2):186-91. PubMed ID: 18190443
[TBL] [Abstract][Full Text] [Related]
9. Primitive myxoid mesenchymal tumor of infancy: a clinicopathologic report of 6 cases.
Alaggio R; Ninfo V; Rosolen A; Coffin CM
Am J Surg Pathol; 2006 Mar; 30(3):388-94. PubMed ID: 16538060
[TBL] [Abstract][Full Text] [Related]
10. Pseudomyogenic hemangioendothelioma: a distinctive, often multicentric tumor with indolent behavior.
Hornick JL; Fletcher CD
Am J Surg Pathol; 2011 Feb; 35(2):190-201. PubMed ID: 21263239
[TBL] [Abstract][Full Text] [Related]
11. Myxoinflammatory fibroblastic sarcoma of the scalp: aggressive behavior at a rare, nonextremity site.
Vroobel K; Miah A; Fisher C; Thway K
Int J Surg Pathol; 2015 Jun; 23(4):292-7. PubMed ID: 25673633
[TBL] [Abstract][Full Text] [Related]
12. Inflammatory myofibroblastic tumor and low-grade myofibroblastic sarcoma: a comparative study of clinicopathologic features and further observations on the immunohistochemical profile of myofibroblasts.
Qiu X; Montgomery E; Sun B
Hum Pathol; 2008 Jun; 39(6):846-56. PubMed ID: 18400254
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic hyalinizing angiectatic tumor revisited: all tumors manifest typical morphologic features of myxoinflammatory fibroblastic sarcoma, further suggesting 2 morphologic variants of a single entity.
Michal M; Kazakov DV; Hadravský L; Agaimy A; Švajdler M; Kuroda N; Michal M
Ann Diagn Pathol; 2016 Feb; 20():40-3. PubMed ID: 26626209
[TBL] [Abstract][Full Text] [Related]
14. Acral myxoinflammatory fibroblastic sarcoma: a report of five cases and review of the literature.
Sakaki M; Hirokawa M; Wakatsuki S; Sano T; Endo K; Fujii Y; Ikeda T; Kawaguchi S; Hirose T; Hasegawa T
Virchows Arch; 2003 Jan; 442(1):25-30. PubMed ID: 12536311
[TBL] [Abstract][Full Text] [Related]
15. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma.
Doyle LA; Möller E; Dal Cin P; Fletcher CD; Mertens F; Hornick JL
Am J Surg Pathol; 2011 May; 35(5):733-41. PubMed ID: 21415703
[TBL] [Abstract][Full Text] [Related]
16. Myxoinflammatory fibroblastic sarcoma: report of a case and review of the literature.
Alaggio R; Coffin CM; Dall'igna P; Bisogno G; Olivotto A; Di Venosa B; Fassina A
Pediatr Dev Pathol; 2012; 15(3):254-8. PubMed ID: 22372507
[TBL] [Abstract][Full Text] [Related]
17. Myxoinflammatory fibroblastic sarcoma: a tumor not restricted to acral sites.
Jurcić V; Zidar A; Montiel MD; Frković-Grazio S; Nayler SJ; Cooper K; Suster S; Lamovec J
Ann Diagn Pathol; 2002 Oct; 6(5):272-80. PubMed ID: 12376919
[TBL] [Abstract][Full Text] [Related]
18. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
19. Undifferentiated high-grade pleomorphic sarcomas in children: a clinicopathologic study of 10 cases and review of literature.
Alaggio R; Collini P; Randall RL; Barnette P; Million L; Coffin CM
Pediatr Dev Pathol; 2010; 13(3):209-17. PubMed ID: 20055602
[TBL] [Abstract][Full Text] [Related]
20. Hemosiderotic Fibrolipomatous Tumor, Pleomorphic Hyalinizing Angiectatic Tumor, and Myxoinflammatory Fibroblastic Sarcoma: Related or Not?
Boland JM; Folpe AL
Adv Anat Pathol; 2017 Sep; 24(5):268-277. PubMed ID: 28375867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]